WATCH LIVE: Officials give update after shooter reported near Emory University in Atlanta
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
12 minutes ago
- Gizmodo
Handsoaps Recalled Over Bacteria That Can Cause Sepsis
Four brands of soap and skin products are being recalled by their manufacturer after they were discovered to potentially be contaminated with bacteria that can cause infections, and even lead to sepsis in immunosuppressed people, according to announcements from the FDA and DermaRite Industries. The products, DermaKleen, KleenFoam, DermaSarra, and PeriGiene, have been recalled nationwide in the U.S. and Puerto Rico over the bacteria Burkholderia cepacia (spelled as cepecia in the FDA press release), though the health agency didn't indicate how the contamination of the soaps may have occurred. The announcements from the FDA and DermaRite Industries also didn't state where the soaps and skin products were sold, though listings online suggest the soaps are often purchased by companies and institutions for use in public facilities. It's not clear how popular the products may be at physical retail stores where the average consumer might buy them for use in the home, though they are available at online retailers like Amazon. Neither DermaRite nor the FDA immediately responded to questions Monday. The FDA's description of the recalled products: 'In healthy individuals with minor skin lesions the use of the product will more likely result in local infections, whereas in immunocompromised individuals the infection is more likely to spread into blood stream leading to life-threatening sepsis,' the company said in a statement posted online. 'To date, DermaRite has not received any reports of adverse events related to this recall.' Consumers who believe they're experiencing issues after using these products are encouraged to contact their doctors. The lot numbers and expiration dates for the recalled products, according to DermaRite: Consumers who have questions about the recall are encouraged to call Mary Goldberg at DermaRite Industries at the number 973-569-9000 x104, Monday through Friday, from 9:00 am to 5:00 pm ET, according to the company's press release. The company can also be reached by email at: [email protected].
Medscape
12 minutes ago
- Medscape
FDA Okays Ketamine-Based Med for Post-Surgical Pain
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical pain. 'This historic FDA approval…is a testament to years of dedicated development,' Fabio Chianelli, chairman and CEO of PharmaTher, said in a release. 'We remain steadfast in our mission to harness the pharmaceutical potential of ketamine for a range of mental health, neurological, and pain disorders,' he added. The company noted that it hopes to expand ketamine development into conditions such as Parkinson's disease, amyotrophic lateral sclerosis, depression, and complex regional pain syndrome. Its product has already received an orphan drug designation for the treatment of Rett syndrome. It added that, among psychedelic and 'psychedelic-adjacent' drugs, ketamine is the only one to be included on a list of Essential Medicines by the World Health Organization. The company initially announced that the FDA had set an approval goal date of April 2024 for KETARx. However, after 'minor deficiencies identified by Quality' were identified, the FDA assigned a new target date of October 2024. As reported by Medscape Medical News at the time, the FDA issued a complete response letter requesting additional information on the application. The final date of August 2025 was set after the company submitted the requested additional information.
Yahoo
41 minutes ago
- Yahoo
Global Telemedicine Market to Grow at 11.3% CAGR Through 2030
"Regional Adoption, Expanding Applications, and Emerging Opportunities Drive Growth in Telemedicine—From Telepsychiatry to IT-Enabled Healthcare Platforms" BOSTON, Aug. 11, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "Global Markets for Telemedicine Technologies" is projected to grow from $146.9 billion in 2025 to $251.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2030. This report offers a comprehensive review of the telemedicine technologies market, focusing on its rapid growth. key players and their competitive strategies, innovations, and regional opportunities, while also examining market drivers like virtual consultations and patient demand for remote care. The market is segmented by hardware, software, and services, and categorized by end-users such as homes and healthcare providers. It also explores emerging technologies, regulatory landscapes, and trends across major regions and countries. Overall, the report underscores telemedicine's expanding role in modern healthcare, driven by digital tools, remote monitoring, and increasing patient adoption. This report is particularly relevant today because telemedicine has gained widespread acceptance following the COVID-19 pandemic, particularly in urban areas. It offers a vital solution for people in rural or remote regions to access healthcare services. Beyond consultations, telemedicine enables patients to undergo regular check-ups, diagnoses, imaging, and even surgeries through virtual platforms. With reduced waiting times and increased convenience, telemedicine has become one of the most efficient ways to connect with physicians and receive timely care. The factors driving the market's growth include: Growing Trend of Asynchronous Telemedicine: Asynchronous telemedicine allows patients and healthcare providers to communicate without needing to be online at the same time. This includes sharing medical data, images, or messages through secure platforms. It enhances flexibility, reduces wait times, and expands access to care, especially in rural or underserved areas. Implementation of the Internet of Things in Telemedicine: IoT devices like wearables and remote sensors are transforming telemedicine by enabling real-time health monitoring. These tools collect and transmit patient data continuously, allowing for timely interventions and personalized care. This integration boosts efficiency and supports proactive healthcare delivery. Telemedicine for Chronic Disease Management: Telemedicine is increasingly used to manage chronic conditions such as diabetes, hypertension, and heart disease. It facilitates regular virtual consultations, remote monitoring, and patient education, helping reduce hospital visits and improve long-term health outcomes through consistent care. Advances in Digital Healthcare Systems: Modern digital healthcare systems, including electronic health records (EHRs) and AI-powered diagnostics, are streamlining telemedicine services. These technologies improve data sharing, enhance decision-making, and support integrated care models, making telemedicine more effective and scalable. Evolving Insurance Sectors for Telemedicine: Insurance providers are adapting to the rise of telemedicine by expanding coverage for virtual consultations and remote care services. This shift makes telemedicine more accessible and affordable, encouraging broader adoption among patients and healthcare providers alike. Request a sample copy of the global market for telemedicine technologies report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $133.7 billion Market size forecast $251.5 billion Growth rate CAGR of 11.3% from 2025 to 2030 Segments covered Application, Business Area, End User, and Region Regions covered North America, Europe, Asia-Pacific, South America and the Middle East and Africa (MEA) Countries covered U.S., Canada, Germany, the U.K., Italy, France, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico and Argentina Market drivers • Growing trend of asynchronous telemedicine. • Implementation of the Internet of Things in telemedicine. • Use of telemedicine for chronic disease management. • Advances in digital healthcare systems. • Evolving insurance sectors for telemedicine. Interesting facts: Telemedicine technology will likely reduce the number of in-patient visits in hospitals, clinics and other healthcare systems. Telesurgery has been successful in countries like South Korea, India, and China in performing surgery using robotics, smart devices, and video calling from anywhere. Emerging startups: Sprinter Health: Sprinter Health focuses on reaching patients who cannot contact any healthcare system. The company provides a clinician network and a tech platform to solve problems by bringing critical preventive care to disabled patients. Orange Health: Orange Health is among the fastest-growing diagnostic-tech companies in India. The company provides consumers with 60 mintues of at-home testing for over 2,000 tests with fast results. Bug Sense Diagnostics: Bug Sense has developed a low-cost, fast, easy-to-use point-of-care diagnostic device for urinary tract infections (UTIs). BugSense provides the same accuracy as other culture devices but does not require an incubation machine or other medical devices. The report addresses the following questions: What are the projected size and growth rate for the global market for telemedicine technologies? The global market for telemedicine technologies was valued at $133.7 billion in 2024. The telecardiology segment recorded a value of $28.3 billion in 2024, which is projected to grow at a CAGR of 14.1% during the forecast period. 2. Which market segments are covered in the report? The global market for telemedicine technologies is segmented by: Business Area. End-user. Application. 3. Which business area will be dominant through 2030? Services are expected to be the dominant business area through the end of the forecast period. 4. Which application market is growing fastest? Telecardiology and telepsychiatry applications are the fastest-growing markets. Market leaders include: AMERICAN WELL AMC HEALTH CISCO SYSTEMS INC. CVS HEALTH DOXIMITY INC. GE HEALTHCARE GLOBALMED HOLDINGS LLC. IMEDTAC CO. LTD. KONINKLIJKE PHILIPS N.V. MEDTRONIC SIEMENS HEALTHINIEERS AG SHL TELEMEDICINE TELADOC HEALTH INC. TELESPECIALISTS TIGERCONNECT Related reports: Elder Care Services and Assistive Devices: Global Markets: This report highlights key trends shaping the elder care services and assistive devices market. It explores how factors like R&D, technological innovations, and government initiatives are driving growth, while also addressing challenges such as rising competition. The study provides insights into strategic moves like M&A and collaborations, evaluating their strengths and weaknesses in the context of evolving customer needs and emerging technologies. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo: View original content to download multimedia: SOURCE BCC Research LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
